Modus Outcomes, a Division of THREAD, Cambridge, MA, USA.
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Adv Ther. 2022 Jun;39(6):2796-2805. doi: 10.1007/s12325-022-02096-3. Epub 2022 Apr 16.
Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare, severely disabling, autosomal dominant, congenital disease characterized by progressive multi-focal heterotopic ossification (HO) of skeletal muscle, ligaments, tendons, and fascia. Past FOP studies have focused on the clinical aspects of the disease; therefore, there is a paucity of qualitative research on the patient experience. Our objective was to better understand the experience of children and adolescents living with FOP from their and their parents' perspectives.
We conducted a qualitative research study comprising in-depth, open-ended interviews with children and adolescents with FOP and their parents. Semi-structured interviews were conducted via phone call or Microsoft Teams with parent-child dyads (n = 11), adolescents (n = 6), and two clinicians. Children/adolescents and their parents were asked open-ended questions to elicit their daily experience of FOP.
Concepts were organized into two major themes: symptoms of FOP and the impact of FOP on daily life. Symptoms of FOP reported by children/adolescents, parents, and clinicians were pain, swelling, redness, and stiffness. Functional impacts of flares and FOP in general included accommodations, mobility, activities of daily living, daily activities, and social activities. Impacts were attributed to the difficulties children and adolescents faced living with a disease that prohibited common activities.
This research documented the experience of children and adolescents with FOP and its effects on their daily lives. It provides a conceptual model for further exploration of the symptoms and impacts important to children and adolescents with FOP and their parents. Children and adolescents and their parents offered novel insights into life with the disease that have not previously been discussed in published literature. Future studies should build upon our conceptual model to create a holistic view of the patient experience of FOP, to inform clinical practice, and the assessment of the patient experience in clinical trials for the disease.
进行性骨化性纤维发育不良(FOP)是一种罕见的、严重致残的常染色体显性遗传性先天性疾病,其特征是骨骼肌、韧带、肌腱和筋膜的进行性多灶性异位骨化(HO)。过去的 FOP 研究主要集中在疾病的临床方面;因此,关于患者体验的定性研究很少。我们的目的是从儿童及其父母的角度更好地了解患有 FOP 的儿童和青少年的体验。
我们进行了一项定性研究,包括对患有 FOP 的儿童和青少年及其父母进行深入的、开放式访谈。通过电话或 Microsoft Teams 对亲子二人组(n=11)、青少年(n=6)和两位临床医生进行半结构式访谈。向儿童/青少年及其父母提出开放式问题,以了解他们日常生活中 FOP 的体验。
概念被组织成两个主要主题:FOP 的症状和 FOP 对日常生活的影响。儿童/青少年、父母和临床医生报告的 FOP 症状包括疼痛、肿胀、发红和僵硬。FOP 发作和一般情况下的功能影响包括适应、移动性、日常生活活动、日常活动和社交活动。这些影响归因于儿童和青少年在因疾病而无法进行常见活动时所面临的困难。
这项研究记录了患有 FOP 的儿童和青少年的体验及其对日常生活的影响。它提供了一个概念模型,用于进一步探讨对患有 FOP 的儿童和青少年及其父母重要的症状和影响。儿童和青少年及其父母提供了对疾病生活的新见解,这些见解以前没有在已发表的文献中讨论过。未来的研究应在我们的概念模型基础上进一步探索 FOP 患者的整体体验,为临床实践和疾病临床试验中患者体验的评估提供信息。